Logo Logo
Hilfe
Hilfe
Switch Language to English

Falkenburger, Björn ORCID logoORCID: https://orcid.org/0000-0002-2387-526X; Fanciulli, Alessandra ORCID logoORCID: https://orcid.org/0000-0002-2854-4179; Pötter-Nerger, Monika ORCID logoORCID: https://orcid.org/0000-0001-7680-2147; Eimeren, Thilo van ORCID logoORCID: https://orcid.org/0000-0002-6951-2325; Classen, Joseph ORCID logoORCID: https://orcid.org/0000-0001-7182-6967; Höglinger, Günter ORCID logoORCID: https://orcid.org/0000-0001-7587-6187; Redecker, Christoph ORCID logoORCID: https://orcid.org/0000-0001-7452-0525; Winkler, Jürgen und Klucken, Jochen ORCID logoORCID: https://orcid.org/0000-0001-6645-9437 (2025): Clinical utility of digital technologies in Parkinson’s disease. In: Journal of Neural Transmission [Forthcoming]

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Digital health technologies (DHTs) are on the verge of changing treatment of Parkinson’s disease (PD). This narrative overview article describes DHTs that are already used or in development, focusing on technologies available in Germany and on their clinical utility. Examples include applications that are primarily used by patients, i.e., tools for patient education and empowerment, but also stand-alone interventions improving clinical outcomes including motor and non-motor symptoms. In Germany, these patient-centered DHTs fall under the HTA framework of digital health applications (DIGA). DHT for telemonitoring, in contrast, are designed to support physicians and other healthcare providers and therefore medical devices. DHT are also used increasingly as exploratory endpoints in trials testing neuroprotective treatments.

Dokument bearbeiten Dokument bearbeiten